Insurance Coverage Mandates and the Adoption of Digital Breast Tomosynthesis.

ABSTRACT:

Importance

Digital breast tomosynthesis (DBT) is a breast cancer screening modality that has gained popularity in recent years. Although insurance coverage for DBT is not mandated under the Patient Protection and Affordable Care Act, several states have required coverage without cost sharing for private insurers.

Objective

To evaluate the association between state-level insurance coverage mandates for DBT and changes in DBT use, price, and out-of-pocket payments.

Design, setting, and participants

This cohort study used an event-study design with repeated cross-sectional observations of US states. Data were obtained from the Blue Cross Blue Shield Axis database for commercially insured women aged 40 to 64 years who underwent screening mammography between January 1, 201

SUBMITTER: Richman IB 

PROVIDER: S-EPMC8956980 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature